Full Text View
Tabular View
No Study Results Posted
Related Studies
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
This study is currently recruiting participants.
Verified April 2013 by National Cancer Institute (NCI)
Study NCT01055314   Information provided by National Cancer Institute (NCI)

First Received on January 22, 2010.   Last Updated on April 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Adult Rhabdomyosarcoma
Alveolar Childhood Rhabdomyosarcoma
Stage IV Adult Soft Tissue Sarcoma
Additional conditions recognized in this trial
Rhabdomyosarcoma
Rhabdomyosarcoma, Embryonal
Sarcoma
More general conditions related to this trial
Myosarcoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Neoplasms, Muscle Tissue
Interventions listed in this trial
cixutumumab
doxorubicin hydrochloride
irinotecan hydrochloride
liposomal vincristine sulfate
ifosfamide
etoposide
cyclophosphamide
dactinomycin
temozolomide
Additional drug interventions recognized in this trial
Antibodies
Antibodies, Monoclonal
Camptothecin
Dacarbazine
Doxorubicin
Etoposide phosphate
Irinotecan
Isophosphamide mustard
Vincristine
More general drug interventions related to this trial
Alkylating Agents
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Protein Synthesis Inhibitors
Radiation-Sensitizing Agents
Therapeutic Uses
Topoisomerase I Inhibitors
Topoisomerase Inhibitors
Tubulin Modulators
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services